To being with, we analyzed the expression levels of SEMA3C protein expression in tamoxifen-resistant (TamR) cells generated via two different conditions, representing distinct endocrine therapy strategies vs. tamoxifen sensitive (MCF7) ER+ breast cancer cell lines cells along with MCF10A [37]. The gene discussed is SEMA3C; the disease is breast carcinoma.